Financing · Jun 15, 2026NeoGenomics proposes offering of convertible senior notes due 2032 to qualified institutional buyersNEONeogenomics IncNeoGenomics, Inc. announced the commencement of a proposed offering of convertible senior notes due 2032 to qualified institutional buyers under Rule 144A. NeoGenomics, Inc. is a biotechnology company providing precision oncology testing services.
